Rotavirus

12 registered clinical trials studyying Rotavirus.

Status	Trial	Sponsor	Phase
Completed	Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam NCT03587389	Oxford University Clinical Research Unit, Vietnam	Phase 4
Completed	Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavi NCT02141204	GlaxoSmithKline	Phase 3
Completed	Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT- NCT02907216	GlaxoSmithKline	Phase 4
Unknown	Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon NCT02177799	Shaikh Ragheb Harb Hospital	—
Completed	The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan NCT03031743	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	—
Unknown	The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine NCT02153866	Sichuan Center for Disease Control and Prevention	Phase 4
Completed	Molecular Epidemiology of Rotavirus Diarrhea Among Infants and Young Children Attending Maua Methodist Hospita NCT00820261	Institute of Primate Research	—
Completed	Effectiveness of Monovalent Rotavirus Vaccine (RV1) NCT01871038	Children's Hospital Medical Center, Cincinnati	—
Terminated	A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027) NCT00836498	Merck Sharp & Dohme LLC	Phase 1
Completed	Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED) NCT00718237	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021) NCT00496054	Merck Sharp & Dohme LLC	Phase 3
Completed	V260 Registration Study (V260-013)(COMPLETED) NCT00166517	Merck Sharp & Dohme LLC	Phase 3